110 related articles for article (PubMed ID: 38877529)
1. Immune profiling of mouse lung adenocarcinoma paraffin tissues using multiplex immunofluorescence panel: a pilot study.
Zhai J; Tamegnon A; Jiang M; Pandurengan RK; Parra ER
Lab Anim Res; 2024 Jun; 40(1):24. PubMed ID: 38877529
[TBL] [Abstract][Full Text] [Related]
2. Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.
Parra ER; Zhai J; Tamegnon A; Zhou N; Pandurengan RK; Barreto C; Jiang M; Rice DC; Creasy C; Vaporciyan AA; Hofstetter WL; Tsao AS; Wistuba II; Sepesi B; Haymaker C
Sci Rep; 2021 Feb; 11(1):4530. PubMed ID: 33633208
[TBL] [Abstract][Full Text] [Related]
3. Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue.
Parra ER; Ferrufino-Schmidt MC; Tamegnon A; Zhang J; Solis L; Jiang M; Ibarguen H; Haymaker C; Lee JJ; Bernatchez C; Wistuba II
Sci Rep; 2021 Apr; 11(1):8511. PubMed ID: 33875760
[TBL] [Abstract][Full Text] [Related]
4. Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues.
Parra ER; Uraoka N; Jiang M; Cook P; Gibbons D; Forget MA; Bernatchez C; Haymaker C; Wistuba II; Rodriguez-Canales J
Sci Rep; 2017 Oct; 7(1):13380. PubMed ID: 29042640
[TBL] [Abstract][Full Text] [Related]
5. Validation of multiplex immunofluorescence and digital image analysis for programmed death-ligand 1 expression and immune cell assessment in non-small cell lung cancer: comparison with conventional immunohistochemistry.
Wu J; Mao L; Sun W; Yang X; Wang H; Liu X; Chi K; Huang X; Lin D
J Clin Pathol; 2022 Jul; 75(7):452-458. PubMed ID: 33782193
[TBL] [Abstract][Full Text] [Related]
6. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.
Parra ER; Villalobos P; Behrens C; Jiang M; Pataer A; Swisher SG; William WN; Zhang J; Lee J; Cascone T; Heymach JV; Forget MA; Haymaker C; Bernatchez C; Kalhor N; Weissferdt A; Moran C; Zhang J; Vaporciyan A; Gibbons DL; Sepesi B; Wistuba II
J Immunother Cancer; 2018 Jun; 6(1):48. PubMed ID: 29871672
[TBL] [Abstract][Full Text] [Related]
7. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.
Daunke T; Beckinger S; Rahn S; Krüger S; Heckl S; Schäfer H; Wesch D; Pilarsky C; Eckstein M; Hartmann A; Röcken C; Wandmacher AM; Sebens S
Front Immunol; 2023; 14():1157397. PubMed ID: 37449210
[TBL] [Abstract][Full Text] [Related]
8. Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues.
Hernandez S; Rojas F; Laberiano C; Lazcano R; Wistuba I; Parra ER
Front Mol Biosci; 2021; 8():667067. PubMed ID: 33996912
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.
Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475
[TBL] [Abstract][Full Text] [Related]
10. Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.
Sanchez K; Kim I; Chun B; Pucilowska J; Redmond WL; Urba WJ; Martel M; Wu Y; Campbell M; Sun Z; Grunkemeier G; Chang SC; Bernard B; Page DB
Breast Cancer Res; 2021 Jan; 23(1):2. PubMed ID: 33413574
[TBL] [Abstract][Full Text] [Related]
11.
Lin Y; Wang Y; Xue Q; Zheng Q; Chen L; Jin Y; Huang Z; Li Y
Transl Lung Cancer Res; 2024 May; 13(5):1010-1031. PubMed ID: 38854942
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between Immune Microenvironment Features and EGFR Mutation Status
in Lung Adenocarcinoma].
Zhu H; Chen P; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Yuan F; Yu X; Sun Q; Ji J; Wang S; Liu T; Xu L
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):204-216. PubMed ID: 37035883
[TBL] [Abstract][Full Text] [Related]
13. Development of an automated combined positive score prediction pipeline using artificial intelligence on multiplexed immunofluorescence images.
Vahadane A; Sharma S; Mandal D; Dabbeeru M; Jakthong J; Garcia-Guzman M; Majumdar S; Lee CW
Comput Biol Med; 2023 Jan; 152():106337. PubMed ID: 36502695
[TBL] [Abstract][Full Text] [Related]
14. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
[TBL] [Abstract][Full Text] [Related]
15. Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment.
Gorris MAJ; Halilovic A; Rabold K; van Duffelen A; Wickramasinghe IN; Verweij D; Wortel IMN; Textor JC; de Vries IJM; Figdor CG
J Immunol; 2018 Jan; 200(1):347-354. PubMed ID: 29141863
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.
Mori H; Bolen J; Schuetter L; Massion P; Hoyt CC; VandenBerg S; Esserman L; Borowsky AD; Campbell MJ
J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):417-432. PubMed ID: 33590360
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Assessment of the Immune Microenvironment in Patients With Iatrogenic Laryngotracheal Stenosis.
Davis RJ; Lina I; Green B; Engle EL; Motz K; Ding D; Taube JM; Gelbard A; Hillel AT
Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1257-1264. PubMed ID: 33290179
[TBL] [Abstract][Full Text] [Related]
18. Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study.
Qian H; Pang J; Wan C; Mei X; Liao J; Wang B; Milano MT; Suwinski R; Inno A; Du Y
Transl Cancer Res; 2024 May; 13(5):2509-2517. PubMed ID: 38881925
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
Griguolo G; Tosi A; Dieci MV; Fineberg S; Rossi V; Ventura A; Bottosso M; Bauchet L; Miglietta F; Jacob J; Rigau V; Fassan M; Jacot W; Conte P; Rosato A; Darlix A; Guarneri V
Neuro Oncol; 2022 Dec; 24(12):2146-2158. PubMed ID: 35609559
[TBL] [Abstract][Full Text] [Related]
20. Immune Marker Spatial Distribution and Clinical Outcome after PD-1 Blockade in Mismatch Repair-deficient, Advanced Colorectal Carcinomas.
Saberzadeh-Ardestani B; Graham RP; McMahon S; Ahanonu E; Shi Q; Williams C; Hubbard A; Zhang W; Muranyi A; Yan D; Jin Z; Shanmugam K; Sinicrope FA
Clin Cancer Res; 2023 Oct; 29(20):4268-4277. PubMed ID: 37566222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
